Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...
Human emotional development is deeply embedded in social and cultural contexts, yet much of our scientific understanding is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback